Advisors Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$189K	Hold	4,009	–	–	﹤0.01%	1124
2025 Q1	$157K	Buy	4,009 +1,803	+82%	+$70.4K	﹤0.01%	1137
2024 Q4	$119K	Buy	+2,206	New	+$119K	﹤0.01%	1195